ArticleArchives of medical science : AMS2022
2022: the year in cardiovascular disease - the year of upfront lipid lowering combination therapy.
Maciej Banach et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
29 papers cite it
this paperpooled itcites it